AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 62 min read$VTIX

Allan David Robert Malcolm sold $193K of VTIX

Allan David Robert Malcolm (COO) sold 126,650 shares of Virtuix Holdings Inc. (VTIX) at an average of $1.53 ($1.47–$1.70, $0.19M total) across 3 trades over 2026-08-03 to 2026-08-05 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Allan David Robert Malcolm
Published Aug 6, 2026, 1:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 2:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$VTIX
Neutral
medium confidence
Mentioned
$VTIX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VTIXNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, trade dates, and post-transaction holdings (0 shares) by the COO under a 10b5-1 plan.

02

Market read

Traders may briefly reassess sentiment around insider behavior, but the 10b5-1 structure reduces interpretive weight.

03

What to watch

The filing does not disclose whether other insiders or the company also sold/bought around the same window, which could matter for interpreting sentiment.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-05 for sales dated 2026-08-03 to 2026-08-05

Background

The article is an SEC Form 4 insider transaction disclosure for Virtuix Holdings Inc.

Company-level read

Ticker impact

$VTIXNeutralMedium confidence
Context

Virtuix COO Allan Malcolm sold 126,650 shares in open-market trades under a 10b5-1 plan, leaving 0 shares after the sale.

Expected impact

Likely limited, short-lived sentiment impact; no clear directional fundamental signal from the filing alone.

Evidence & confidence

The filing specifies an open-market sale under a pre-arranged Rule 10b5-1 plan and provides no accompanying company news, guidance, or event risk.

Market effects

Sector

Minimal; insider sale in a single microcap does not meaningfully reset sector fundamentals.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the trades were executed under a pre-arranged 10b5-1 plan, the sale may reflect liquidity planning rather than bearish expectations.

Key entities

  • issuer
    Virtuix Holdings Inc.

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Allan David Robert Malcolm

    COO and officer/director who sold shares under a Rule 10b5-1 plan.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

VTIX insider trading history →

Related articles

SEP 9
$VTIXMed

Quarterly revenue beat analyst expectations by more than 50% at Virtuix

Virtuix (VTIX) reported quarterly revenue exceeding analyst expectations by over 50%, driven by strong consumer demand for its Omni One platform. The company will present at the H.C. Wainwright conference, highlighting expansions into defense, robotics, healthcare, and enterprise markets, including partnerships with Tesla and the U.S. Marine Corps. VTIX stock declined 9.52% on the news.

stocktitan.net2 min
AUG 26
$VTIXMed

Research firm sees 644% potential upside for Virtuix; orders rose 72% after Meta partnership

Emerging Growth Research reaffirmed its Buy-Emerging rating and $9.00 price target for Virtuix (VTIX), implying 644% upside. Q1 2027 revenue was $0.8M, down 26% YoY but above estimates, driven by a 72% rise in new orders post-Meta partnership. Gross margin expanded to 30%, and EPS improved sequentially to $(0.22). The firm projects 19% and 275% revenue growth for fiscal 2027 and 2028, respectively, but notes execution and financing risks.

stocktitan.net2 min
AUG 20
$VTIXMed

Virtuix Holdings Inc. (VTIX): Results of Operations and Financial Condition

Virtuix Holdings Inc. (VTIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Virtuix Reports First Quarter Fiscal Year 2027 Results as Omni One Orders Increase 150% Following Meta Launch Orders Increased 72% Year-over-Year and Approximately 150% Since the Launch of Omni One for Quest as Meta Launch Drives Accelerating Consumer Demand Gross Pr

SEC EDGAR 8-K2 min
AUG 19
$VTIXHigh

Virtuix Q1 sales $767K, EPS ($0.22) beat estimates

Virtuix (VTIX) reported Q1 FY2027 net sales of $767K, beating estimates, with a net loss per share of ($0.22). Gross profit rose 29% to $227K, driven by higher selling prices. Operating expenses increased 86% to $4.1M. The company secured its first Omni One Enterprise sale to Tesla. Cash reserves stood at $7.4M. The earnings release and conference call were rescheduled to August 19-20, 2026, due to a new audit firm's review.

scanx.trade3 min
AUG 19
$VTIXMed

Virtuix Reports 72% Year-over-Year Order Growth, Margin Expansion, and New Defense, Enterprise, and Healthcare Wins in Fiscal Q1 2027

Virtuix reported a 72% year-over-year increase in orders and a 29% rise in gross profit for Q1 2027. Gross margin expanded to 30% from 17%. The company secured new defense, enterprise, and healthcare contracts, including deals with Tesla, NASA, and the U.S. Marine Corps. Net sales were $0.8 million, down 26% year-over-year, but orders surged.

quiverquant.com2 min